x
0 Activities
0 Activities
No Saved Activities
Please wait
Search
Format
Interactive Case
Podcast
Primers/Supplements
Webinar
Videos
View All Education
All France Foundation Content
Credit Type
Format
Credits
Specialty Area
Allergy/Clinical Immunology
Hepatology
Blood Management
Cardiology
Dermatology
Endocrinology
Epileptology
Family Medicine
Gastroenterology
Genetic Counselor
Genomic Medicine
Hematology
Hospice/Palliative Care
Hospitalist
Internal Medicine
Medical Laboratory Scientist
Neonatal/Perinatal
Neurology
Neuromuscular Specialist
Neuropsychology
Neurosurgery
Nurse
Nurse Practitioner
Nutrition
Ob/Gyn & Women's Health
Occupational Therapy
Oncology
Opthalmology
Orthopedic Surgery
Pediatrics
Pharmacist
Physical Medicine & Rehabilitation
Physician Assistant
Psychiatry/Mental Health
Pulmonary
Radiology
Rheumatology
Disease Area
1
2
»
End
Page 1 of 2
Results 1 - 75 of 79
15
30
60
75
150
Spotlight On Systemic Sclerosis: Pathophysiology, Presentation & Emerging Evidence
Updates in FVllla Mimetics: Advancing Hemophilia Today and Tomorrow (Online Module)
Beyond Routine Recovery: Treating Atypical Postpartum Complications
Beyond Preeclampsia: Recognizing and Responding to Rare Complications
Thrombotic Threats in Early Pregnancy: Unraveling Rare Blood Disorders
Monograph: A New Era for Hemophilia Treatment: Common Goals, Unique Perspectives
Symposium: A New Era for Hemophilia Treatment: Common Goals, Unique Perspectives
Unraveling Cancer Pain Dynamics Adaptive Learning Module: A REMS-Compliant CE Activity
Cleveland Clinic Tall Rounds: Post‐diagnostic Monitoring of Cardiac Amyloidosis
Rapid Recap: A New Era for Hemophilia Treatment: Common Goals, Unique Perspectives
Cleveland Clinic Tall Rounds: Treating Confirmed ATTR
Weight Management in Community Health: Bridging Systems and Care Coordination
Microlearning: Novel Approaches Under Investigation in Hemophilia
Microlearning: Neutralizing Antibodies in Hemophilia
Microlearning: Durability of Gene Therapy in Hemophilia
Evolutions in the Management of DMD: Treatment Implications for the Present and Future
Hemophilia Gene Therapy: Shared Decision Making - Clinical Companion Guide
Risks and Benefits of Hemophilia Gene Therapy: An EXPLORE Learning Experience
A Changing Conversation: Delaying T1D Onset
Contemporary Strategies: Diagnosing ATTR Amyloidosis
Encouraging Shared Decision-Making with MS Patients
Cognitive Impairment Associated With Schizophrenia
Recent Developments in Immune Therapies for Multiple Sclerosis
The Connection Between Viruses and Other Factors Contributing to the Development of MS
Comorbidities and Selection of DMTs
Management of Breakthrough Disease Activity in MS
COVID-19 Associated ARDS
COVID-19 and Comorbid ILD
Minimizing Neurodegenerative Damage in Patients with MS
Recognizing Progressive Disease: A Challenge in the MS Clinic
DMT Treatment Review
IPF Animated Video Series: Micro-learning focusing on the soft skills
Palliative Care for mRCC
Salvage Therapies for Metastatic Renal Cell Carcinoma
Is There Still a Role For Cytoreductive Nephrectomy
Management of Rare RCC Histologies
Contemporary Topics in RCC: Tumor Board
End of Life in IPF
Comprehensive Care of the ILD Patient–Focus on Symptoms
Developing an Action Plan to Manage IPF
Diagnosis of Interstitial Lung Disease
Applying Principles of Pain Management
Patient Case: Osteoarthritis (OA) of the Knee
Patient Case: Lower Back Pain
Personalized Medicine for Improving Asthma Care: An Animated Video Series
Discussions with Patients to Optimize Asthma Control
Who Should be Targeted For Treatment With Biologic Therapy?
Endotypes and Phenotypes in Asthma
Mechanisms of Action of Biologic Therapies for Severe Asthma
Approved Medications for the Treatment of Severe Asthma
Engage Your Patients in Shared Decision-Making
Is It IPF or Cardiovascular Disease?
Interstitial Pneumonia with Autoimmune Features
How to Identify Progressive Fibrosing ILD
When Is It a Connective Tissue Disease?
How to Use IPF Guidelines to Make a Diagnosis
Biosimilars: Applying the Science to Hematology/Oncology Practice
Considering Biosimilars in Patients Failing their Initial Biologic
When to Switch? Biologically Experienced Patients with Spondyloarthritis
Innovator or Biosimilar for a Patient with Rheumatoid Arthritis
Ulcerative Colitis: What Can You Expect When a Patient is Switched to a Biosimilar?
Biosimilars in Patients with Crohn’s Disease Failing an Initial Biologic
Innovator or Biosimilar for a Patient with Ulcerative Colitis?
Switching Between Biologics: Is a Biosimilar an Option?
When to Switch? Biologically Experienced Psoriasis Patients
Innovator or Biosimilar for a Patient with Psoriasis
Interchangeability and Pharmacy-Level Substitution
FDA Criteria: Biosimilar Approval, Manufacturing, & Naming
What is the Difference Between a Biosimilar and a Generic?
What is a Biologic?
Sorting it Out: Biologics, Biosimilars, Small Molecule Drugs, and Generics
Are You Ready to Use Biosimilars in Your Practice?
Health Care Providers’ Perspectives on Biosimilars: Based in Fact or Not?
Pharmacovigilance and Biosimilars: Any Special Considerations?
Interchangeability and Biosimilars: What will this Mean for Clinical Practice?
1
2
»
End
Page 1 of 2
A ACCME Accredited provider.
The France Foundation ©
10 Vista Drive, Old Lyme, CT USA
Search
Home
Education
Register
Contact Us
Login
This site uses cookies. By continuing to use this website, you agree to their use. For details, please check our
Privacy Policy
.
I accept
